Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

Clinical trial NCT00066989 · COMPLETED

Trial details

NCT number: NCT00066989
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcal Infections

Start date: 2003-07-01
Primary completion: 2004-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.